Byeong Chae Kim Selected Research

technetium 99m ethylenedicysteine-metronidazole

4/2003

Prognostication of recovery in patients with acute ischemic stroke through the use of brain SPECT with Technetium-99m--labeled metronidazole.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Byeong Chae Kim Research Topics

Disease

3	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2017
2	Stroke (Strokes) 06/2015 - 08/2013
2	Pathologic Constriction (Stenosis) 06/2015 - 11/2005
2	Infarction (Infarctions) 06/2015 - 04/2003
2	Ischemic Stroke 11/2005 - 04/2003
1	Dementia (Dementias) 01/2024
1	Disease Progression 01/2024
1	Cognitive Dysfunction 01/2024
1	Prodromal Symptoms 01/2020
1	Mixed Dementias 12/2018
1	Hemorrhage 08/2013
1	Transient Ischemic Attack 11/2005
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 02/2004
1	Arthritis (Polyarthritis) 02/2004
1	Myasthenia Gravis 02/2004

Drug/Important Bio-Agent (IBA)

2	Amyloid (Amyloid Fibrils)IBA 01/2024 - 12/2018
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Apolipoproteins E (ApoE)IBA 01/2020
1	Metronidazole (Metric)FDA LinkGeneric 04/2003
1	technetium Tc 99m bicisate (Neurolite)FDA Link 04/2003
1	technetium 99m ethylenedicysteine-metronidazoleIBA 04/2003

Therapy/Procedure

3	Therapeutics 01/2017 - 11/2005
2	Stents 06/2015 - 08/2013
2	Thrombectomy 06/2015 - 08/2013
1	Vascular Access Devices (Arterial Line) 08/2013
1	Thymectomy 02/2004